Henrike Veith

1.8k total citations
17 papers, 787 citations indexed

About

Henrike Veith is a scholar working on Molecular Biology, Cancer Research and Pharmacology. According to data from OpenAlex, Henrike Veith has authored 17 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Pharmacology. Recurrent topics in Henrike Veith's work include Cancer, Hypoxia, and Metabolism (8 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Henrike Veith is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Metabolomics and Mass Spectrometry Studies (4 papers). Henrike Veith collaborates with scholars based in United States, Canada and Switzerland. Henrike Veith's co-authors include Douglas S. Auld, Christopher P. Austin, Min Shen, James Inglese, Noel Southall, Ruili Huang, Matthew B. Boxer, William Leister, Craig J. Thomas and Matthew G. Vander Heiden and has published in prestigious journals such as Nature Biotechnology, Analytical Biochemistry and Biochemical Journal.

In The Last Decade

Henrike Veith

17 papers receiving 761 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henrike Veith United States 14 507 315 212 130 86 17 787
Lu Tan United Kingdom 14 417 0.8× 96 0.3× 297 1.4× 127 1.0× 42 0.5× 22 702
Ana Conejo‐García Spain 20 599 1.2× 163 0.5× 85 0.4× 36 0.3× 404 4.7× 61 998
Raynard L. Bateman United States 12 754 1.5× 165 0.5× 84 0.4× 37 0.3× 42 0.5× 15 1.1k
William Loging United States 15 575 1.1× 105 0.3× 390 1.8× 114 0.9× 48 0.6× 19 899
John F. Schindler United States 15 623 1.2× 122 0.4× 75 0.4× 40 0.3× 159 1.8× 21 992
Chaya Duraiswami United States 11 534 1.1× 100 0.3× 296 1.4× 22 0.2× 124 1.4× 14 816
Bernard Pirard Switzerland 16 536 1.1× 224 0.7× 194 0.9× 33 0.3× 165 1.9× 31 915
Ola Fjellström Sweden 20 550 1.1× 53 0.2× 83 0.4× 60 0.5× 85 1.0× 40 854
Thomas Harrity United States 17 611 1.2× 107 0.3× 136 0.6× 34 0.3× 257 3.0× 23 1.1k
Éric Therrien Canada 21 649 1.3× 88 0.3× 237 1.1× 43 0.3× 411 4.8× 34 1.1k

Countries citing papers authored by Henrike Veith

Since Specialization
Citations

This map shows the geographic impact of Henrike Veith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henrike Veith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henrike Veith more than expected).

Fields of papers citing papers by Henrike Veith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henrike Veith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henrike Veith. The network helps show where Henrike Veith may publish in the future.

Co-authorship network of co-authors of Henrike Veith

This figure shows the co-authorship network connecting the top 25 collaborators of Henrike Veith. A scholar is included among the top collaborators of Henrike Veith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henrike Veith. Henrike Veith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Auld, Douglas S., Henrike Veith, & James J. Cali. (2013). Bioluminescent Assays for Cytochrome P450 Enzymes. Methods in molecular biology. 987. 1–9. 15 indexed citations
2.
Brimacombe, Kyle R., Dimitrios Anastasiou, W. Tempel, et al.. (2013). ML285 affects reactive oxygen species’ inhibition of pyruvate kinase M2. 8 indexed citations
3.
Walsh, Martin J., Kyle R. Brimacombe, Dimitrios Anastasiou, et al.. (2013). ML265: A potent PKM2 activator induces tetramerization and reduces tumor formation and size in a mouse xenograft model. 29 indexed citations
4.
Morgan, Hugh P., Martin J. Walsh, Elizabeth A. Blackburn, et al.. (2012). A new family of covalent inhibitors block nucleotide binding to the active site of pyruvate kinase. Biochemical Journal. 448(1). 67–72. 25 indexed citations
5.
Sun, Hongmao, Henrike Veith, Menghang Xia, et al.. (2012). Prediction of Cytochrome P450 Profiles of Environmental Chemicals with QSAR Models Built from Drug‐Like Molecules. Molecular Informatics. 31(11-12). 783–792. 17 indexed citations
6.
Sun, Hongmao, Henrike Veith, Menghang Xia, Christopher P. Austin, & Ruili Huang. (2011). Predictive Models for Cytochrome P450 Isozymes Based on Quantitative High Throughput Screening Data. Journal of Chemical Information and Modeling. 51(10). 2474–2481. 55 indexed citations
7.
Walsh, Martin J., Kyle R. Brimacombe, Henrike Veith, et al.. (2011). 2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase. Bioorganic & Medicinal Chemistry Letters. 21(21). 6322–6327. 54 indexed citations
8.
Boxer, Matthew B., Jian‐kang Jiang, Matthew G. Vander Heiden, et al.. (2011). Identification of activators for the M2 isoform of human pyruvate kinase Version 3. 2 indexed citations
9.
Jiang, Jian‐kang, Matthew B. Boxer, Matthew G. Vander Heiden, et al.. (2010). Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase. Bioorganic & Medicinal Chemistry Letters. 20(11). 3387–3393. 104 indexed citations
10.
Veith, Henrike, Noel Southall, Ruili Huang, et al.. (2009). Comprehensive characterization of cytochrome P450 isozyme selectivity across chemical libraries. Nature Biotechnology. 27(11). 1050–1055. 163 indexed citations
11.
MacArthur, Ryan, William Leister, Henrike Veith, et al.. (2009). Monitoring Compound Integrity With Cytochrome P450 Assays and qHTS. SLAS DISCOVERY. 14(5). 538–546. 18 indexed citations
12.
Boxer, Matthew B., Jian‐kang Jiang, Matthew G. Vander Heiden, et al.. (2009). Evaluation of Substituted N,N′-Diarylsulfonamides as Activators of the Tumor Cell Specific M2 Isoform of Pyruvate Kinase. Journal of Medicinal Chemistry. 53(3). 1048–1055. 130 indexed citations
13.
Tegley, Christopher M., Vellarkad N. Viswanadhan, Kaustav Biswas, et al.. (2008). Discovery of novel hydroxy-thiazoles as HIF-α prolyl hydroxylase inhibitors: SAR, synthesis, and modeling evaluation. Bioorganic & Medicinal Chemistry Letters. 18(14). 3925–3928. 39 indexed citations
14.
15.
Auld, Douglas S., Ronald L. Johnson, Ya‐Qin Zhang, et al.. (2006). Fluorescent Protein‐Based Cellular Assays Analyzed by Laser‐Scanning Microplate Cytometry in 1536‐Well Plate Format. Methods in enzymology on CD-ROM/Methods in enzymology. 414. 566–589. 23 indexed citations
16.
Büth, Heiko, Henrike Veith, Christian P. Sommerhoff, et al.. (2004). HaCaT keratinocytes secrete lysosomal cysteine proteinases during migration. European Journal of Cell Biology. 83(11-12). 781–795. 41 indexed citations
17.
Veith, Henrike, et al.. (1974). Transformations de steroids par l'abeille Apis mellifica L.. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 47(2). 459–472. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lu Tan Breakdown of academic impact, for papers by Ana Conejo‐García Breakdown of academic impact, for papers by Raynard L. Bateman Breakdown of academic impact, for papers by William Loging Breakdown of academic impact, for papers by John F. Schindler Breakdown of academic impact, for papers by Chaya Duraiswami Breakdown of academic impact, for papers by Bernard Pirard Breakdown of academic impact, for papers by Ola Fjellström Breakdown of academic impact, for papers by Thomas Harrity Breakdown of academic impact, for papers by Éric Therrien
Rankless by CCL
2026